Peroperative hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer [3]

European Journal of Surgical Oncology

Volumn 26, Issue 6, 2000, Pages 630-631

  De Bree, Eelco ^a   Witkamp, Arjen J ^a   Zoetmulder, Frans A N ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MITOMYCIN C;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; HUMAN; HYPERTHERMIC THERAPY; LETTER; PERITONEUM CANCER; PRIORITY JOURNAL; STOMACH CANCER;

EID: 0033787365     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2000.0964     Document Type: Letter

References (8)

1. Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer
2. Intraperitoneal chemo-hyperthermia with Mitomycin C for gastric cancer patients with peritoneal carcinomatosis
3. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery
4. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination
5. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: A randomized controlled study
6. Successful intraoperative hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma
7. Thermic homogeneity and standardization of intraperitoneal chemohyperthermia for peritoneal carcinomatosis
8. Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion